I-Mab to Participate at the Piper Sandler Healthcare Conference

IMAB 11.21.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-12-04
Name of Upcoming Event:Piper Sandler 36th Annual Healthcare Conference
Full Press ReleaseSEC FilingsOur IMAB Tweets

About Gravity Analytica

Recent News

  • 01.08.2025 - I-Mab Announces Open Market Purchases of Company American Depositary Shares by Board Member
  • 01.06.2025 - I-Mab Announces Portfolio Prioritization of Givastomig (CLDN18.2 x 4-1BB Bispecific Antibody) as Lead Clinical Program
  • 12.04.2024 - Piper Sandler 36th Annual Healthcare Conference (In Person)

Recent Filings

  • 01.13.2025 - EX-99.1 EX-99.1
  • 01.13.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]

The 36thAnnual Healthcare Conference will be held inNew York,December 3-5, 2024

ROCKVILLE, Md.,Nov. 21, 2024/PRNewswire/ --I-Mab(NASDAQ: IMAB, the "Company"), aU.S.-based global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced that management will present at the Piper Sandler 36th Annual Healthcare Conference onDecember 4, 2024.

(PRNewsfoto/I-Mab Biopharma)

Piper Sandler 36th Annual Healthcare Conference Presentation Details

Presentation Time

Wednesday, December 4at 4:30 p.m. ET

Presenters

Sean Fu, PhD, MBA, Chief Executive Officer

Phillip Dennis, MD, PhD, Chief Medical Officer

Webcast link

Here

Meetings

One-on-one and small group meetings: December 3 – 4, 2024

ManagementParticipants

Sean Fu, PhD, MBA, Chief Executive Officer

Joseph Skelton, Chief Financial Officer

Phillip Dennis, MD, PhD, Chief Medical Officer

Tyler Ehler, Senior Director, Investor Relations

The webcast will also be available under "Event Calendar" on I-Mab's IR websiteathttps://ir.i-mabbiopharma.com/

For more information, please contact your Piper Sandler representative.

AboutI-Mab

I-Mab(NASDAQ: IMAB) is a US-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer.I-Mabhas established operations inRockville, Maryland, andShort Hills, New Jersey. For more information, please visithttps://www.i-mabbiopharma.comand follow us on LinkedIn and X.

For more information, please contact:

Tyler EhlerSenior Director, Investor RelationsIR@imabbio.com

CisionView original content to download multimedia:https://www.prnewswire.com/news-releases/i-mab-to-participate-at-the-piper-sandler-healthcare-conference-302312202.html

SOURCEI-Mab Biopharma

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com